Romidepsin Completed Phase 0 Trials for Histologically Proven Extranodal NKTcell Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT01913119A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma